Axalta Coating Systems (AXTA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Jul, 2026Executive summary
Q2 2026 revenue decreased 1% year-on-year, with organic sales growth of 2% offset by a 3% revenue loss from the divestment of liquid coatings in India; half-year revenue declined 5% due to FX and divestment impacts.
Operating income for Q2 rose to €251 million (from €214 million), driven by lower cost of sales and positive pricing; half-year operating income increased to €428 million.
Adjusted EBITDA for Q2 was €398 million, up from €393 million, while half-year adjusted EBITDA declined slightly to €743 million.
Net income attributable to shareholders was €232 million for the half-year, with earnings per share stable at €1.35.
Net cash from operating activities in Q2 was €170 million, down from €234 million, mainly due to working capital changes and restructuring payouts.
Net debt increased to €3,127 million at June 30, 2026, mainly due to dividend payments.
Voting matters and shareholder proposals
An Extraordinary General Meeting is scheduled for August 5, 2026, to vote on the proposed merger with Axalta.
Axalta shareholders will receive 0.6539 AkzoNobel shares per Axalta share; AkzoNobel shareholders will own 55% of the combined company post-merger.
A special cash dividend of up to €2.5 billion is planned for AkzoNobel shareholders, conditional on merger completion.
Board of directors and corporate governance
The Board of Management and Supervisory Board approved the interim financial statements and are responsible for ongoing risk oversight.
Key management personnel include the Executive Committee and Supervisory Board; related party transactions are limited to board activities.
Latest events from Axalta Coating Systems
- Record Q2 sales, earnings, and cash flow set the stage for the AkzoNobel merger.AXTA
Q2 2026 - Shareholders to vote on a transformative $25B all-stock merger creating a global coatings leader.AXTA
Proxy filing - Q1 2026 beat guidance with strong cash flow, Mobility growth, and AkzoNobel merger progress.AXTA
Q1 2026 - Record 2025 results, robust governance, and a pending AkzoNobel merger highlight this proxy.AXTA
Proxy filing - Director elections, auditor appointment, and executive pay are up for shareholder vote.AXTA
Proxy filing - Record 2025 margins and EBITDA; major merger and strong 2026 outlook with synergy potential.AXTA
Q4 2025 - Record Q3 sales and margin expansion led to raised 2024 guidance and strong growth outlook.AXTA
Q3 2024 - Record Q2 sales, margin gains, and raised 2024 guidance driven by robust segment growth.AXTA
Q2 2024 - Record 2024 results, margin expansion, and strong 2025 outlook despite macro risks.AXTA
Q4 2024